ask="3.3100"
ask_size="200"
average_daily_volume="4660"
bid="N/A"
bid_size="N/A"
book_value="0.9450"
change="+0.1074"
change_from_200_day_moving_average="-0.2997"
change_from_50_day_moving_average="-0.0787"
change_from_52_week_high="-2.5126"
change_From_52_week_low="0.5174"
change_in_percent="+4.0836%"
close="2.7374"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.4320"
ebitda="-13.18M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.0700"
eps_estimate_next_year="-0.3300"
ex_dividend_date="N/A"
float_shares="23126000"
high="2.7374"
high_52_weeks="5.2500"
last_trade_date="2/21/2017"
last_trade_price="2.7374"
last_trade_size="300"
last_trade_time="1:41pm"
low="2.4800"
low_52_weeks="2.2200"
market_capitalization="97.82M"
moving_average_200_day="3.0371"
moving_average_50_day="2.8161"
name="Oasmia Pharmaceutical AB"
notes="N/A"
one_year_target_price="6.0000"
open="2.4800"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-9.8694%"
percent_change_from_50_day_moving_average="-2.7964%"
percent_change_from_52_week_high="-47.8590%"
percent_change_from_52_week_low="+23.3063%"
previous_close="2.6300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.7831"
price_per_sales="52.0826"
revenue="1.80M"
shares_outstanding="35736000"
short_ratio="0.4300"
stock_exchange="NCM"
symbol="OASM"
volume="6200"
weeks_range_52="2.2200 - 5.2500"
